Detalhe da pesquisa
1.
Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia.
J Transl Med
; 19(1): 117, 2021 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743723
2.
Higher EZH2 expression is associated with extramedullary infiltration in acute myeloid leukemia.
Tumour Biol
; 37(8): 11409-20, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27000755
3.
[Influence of FLT3-ITD Mutation and ITD Length on the Outcome on Patients with Acute Myeloid Leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 26(3): 678-683, 2018 Jun.
Artigo
em Zh
| MEDLINE | ID: mdl-29950203
4.
Influence of initiation time and white blood cell count on the efficacy of cytotoxic agents in acute promyelocytic leukemia during induction treatment.
Biomed Rep
; 9(3): 227-232, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30271598
5.
Gli-1/PI3K/AKT/NF-kB pathway mediates resistance to radiation and is a target for reversion of responses in refractory acute myeloid leukemia cells.
Oncotarget
; 7(22): 33004-15, 2016 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27105509
6.
Association between the concentration of imatinib in bone marrow mononuclear cells, mutation status of ABCB1 and therapeutic response in patients with chronic myelogenous leukemia.
Exp Ther Med
; 11(5): 2061-2065, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27168851
7.
Palliative chemotherapy followed by methylation inhibitor in high-risk acute myeloid leukemia: An in vitro and clinical study.
Mol Clin Oncol
; 3(5): 1139-1144, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26623066
8.
The relationship between clinical feature, complex immunophenotype, chromosome karyotype, and outcome of patients with acute myeloid leukemia in China.
Dis Markers
; 2015: 382186, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25944974
9.
The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients.
Oncotarget
; 6(32): 33612-22, 2015 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26384351